Tag Archives: USPTO

Arkansas Company

Dewmar International BMC, Inc. Takes Steps to Secure Intellectual Property Related to Cannabinoids and the Treatment of Post-Traumatic Stress Disorder

Dewmar International BMC, Inc. Takes Steps to Secure Intellectual Property Related to Cannabinoids and the Treatment of Post-Traumatic Stress Disorder

NEW ORLEANS, Aug. 9, 2017 /Weed Wire/ — Dewmar International BMC, Inc. (the “Company”) (OTC PINK: DEWM) today announced that it has filed documents with the United States Patent and Trademark Office for the treatment of Post-Traumatic Stress Disorder (PTSD) using cannabinoids.

Axim Biotech - MedChew Rx

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

NEW YORK, June 23, 2017 /Weed Wire/ — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment.

dr welch Alexandra Stupple

D|R Welch Breaks Through USPTO Ban on Cannabis Trademarks

LOS ANGELES, May 10, 2017 /Weed Wire/ – D|R Welch Attorneys at Law, a law firm focusing on all business aspects of the cannabis industry, obtained approval from the United States Patent and Trademark Office on House of Dank’s cannabis products, marking a revolutionary milestone for the cannabis industry.

bq7xic1ceaae77r-pnglarge

New U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum Products

NEW YORK, Nov. 16, 2016 /Weed Wire/ — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM), a world leader in hemp cannabinoid research and development, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 9,433,601.

Lexaria - Nicotine - Television

Lexaria Bioscience Announces Issuance of U.S. Patent for Cannabinoid Infused Edibles

KELOWNA, British Columbia, Oct. 26, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is pleased to announce the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 9,474,725 pertaining to Lexaria’s method of improving bioavailability and taste of certain cannabinoid lipophilic active agents in food products.

Lexaria - Nicotine - Television

Lexaria Receives Notice of Allowance of First Patent by US Patent Office

KELOWNA, British Columbia, July 12, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) is very pleased to announce a watershed event in its advancement as a bioscience company: it has just received its first Notice of Allowance for one of its US patent applications from the US Patent and Trademark Office (USPTO).

Pineapple Express

Pineapple Express Inc. Announces Patent-Pending ‘Top-Shelf’ System for Use in Marijuana Dispensaries

LOS ANGELES, Oct. 7, 2015 /Weed Wire/ — Pineapple Express, Inc. (OTC Pink: PNPL) (the “Company”), announced a patent application pending with the USPTO related to an invention called the “Top-Shelf” Display Safe System.

Amfil

Amfil Technologies Inc. Files Provisional Patent Application with the United States Patent and Trademark Office for GROzone Technology Protection; Receives Patent Pending Number

TORONTO, ON, Canada, Aug. 3, 2015 /Weed Wire/ — Amfil Technologies Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE), provider of custom engineering and integration of ozone based technology for the medical marijuana manufacturing industry through the GROzone line of products, today announced that it has submitted a provisional patent application with the United States Patent & Trademark Office under the Patent Cooperation Treaty (PCT) encompassing the ozone technology and delivery system used in the GROzone gaseous and aqueous systems.

Medbox Granted “Seed- to-Sale” Marijuana Monitoring Patent by USPTO

LOS ANGELES, Sept. 2, 2014 /PRNewswire/ – Medbox, Inc. (OTCQB: MDBX) (www.medbox.com), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, today announced that the US Patent and Trademark Office (USPTO) has issued patent #US8818820 and assigned it to Medbox, Inc.


Top